Several stocks that have underperformed in 2024 may be poised for substantial gains in coming months, according to Goldman Sachs. Yet some stocks that have lagged this year could outperform in the first quarter of 2025, the investment bank said. In other words, those are buy-rated stocks where Goldman analysts are out-of-consensus while most of Wall Street is neutral or has a sell rating. Meanwhile, 60% of the 20 analysts covering the stock rate it neutral, and the other 20% carry a sell. Of the 12 analysts who cover Pool on the Street, half rate it hold and 17% have a sell rating.

---

Persons: Goldman Sachs, Goldman, Deep Mehta, Mehta, Donald Trump, Robert F, Kennedy Jr, Kennedy, Goldman –, FactSet, Conagra, TripAdvisor, they're Organizations: Nasdaq, Dow Jones, Industrials, Tech, Goldman, Conagra Brands, Department of Health, Human Services, Food and Drug Administration